Bone marrow transplant for lymphoma: where is the field going?
Gribben
J G
JG
Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. john_gribben@dfci.harvard.edu
D016026:Bone Marrow Transplantation; D019496:Cancer Vaccines / Q000627:therapeutic use; D018572:Disease-Free Survival; D015321:Gene Rearrangement; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics / Q000628:therapy*; D016133:Polymerase Chain Reaction / Q000379:methods; D011379:Prognosis; D012008:Recurrence; D016879:Salvage Therapy; D014178:Translocation, Genetic; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D019496:Cancer Vaccines